Outreach to bone marrow transplant survivors and their primary care doctors can markedly cut skin cancer risk
Experts at City of Hope, one of the nation's largest and most advanced cancer research and treatment organizations, are shining a spotlight on the risk of skin cancer faced by hematopoietic cell transplant (HCT) survivors, as well as the need for early detection. New City of Hope research published in Journal of the National Comprehensive Cancer Network shows how a cost-effective, scalable…
Experts at City of Hope are highlighting the heightened risk of skin cancer for hematopoietic cell transplant (HCT) survivors and the need for early detection through an educational program. HCT survivors have nearly double the risk of squamous cell carcinoma and other skin cancers, with most skin cancers appearing three to five years post-transplant.
A randomized controlled trial published in the Journal of the National Comprehensive Cancer Network found that a cost-effective program could significantly improve screening rates among survivors and their primary care doctors. The program involved mailed educational materials, text reminders, and guidance for physicians on performing full-body skin exams.
Patients who received both patient information and physician guidance completed more self-exams and had 40% higher in-office skin checks compared to those who only received patient education.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
